CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 22 enrolled
Drug / intervention
Topical Myristyl Nicotinate Cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00619060
NCT00619060Phase 1Completed
CompareCT.gov

A Phase I Study of Topical Myristyl Nicotinate Cream on Human Skin in Healthy Volunteers

University of Arizona·interventional·Posted Feb 20, 2008·Updated Mar 10, 2016

In Brief

A Phase 1 clinical trial evaluating Topical Myristyl Nicotinate Cream and Placebo for Healthy. Completed, enrolled 22 participants across 1 site.

Detailed Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of topical myristyl nicotinate cream may stop skin cancer from forming. PURPOSE: This randomized phase I trial is studying the side effects and best way to give topical myristyl nicotinate cream on the skin of healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 20, 2008
Enrollment StartAug 1, 2007
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.4 years ago

Interventions

Topical Myristyl Nicotinate Creamdrug

Participants apply topical myristyl nicotinate to one forearm once daily for 4 weeks.

Placebodrug

Participants apply topical placebo to one forearm once daily for 4 weeks.